Your browser doesn't support javascript.
loading
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.
Wu, Song-Yang; Xu, Ying; Chen, Li; Fan, Lei; Ma, Xiao-Yan; Zhao, Shen; Song, Xiao-Qing; Hu, Xin; Yang, Wen-Tao; Chai, Wen-Jun; Guo, Xiao-Mao; Chen, Xi-Zi; Xu, Yan-Hui; Zhu, Xiao-Yu; Zou, Jian-Jun; Wang, Zhong-Hua; Jiang, Yi-Zhou; Shao, Zhi-Ming.
Affiliation
  • Wu SY; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Xu Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Chen L; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Fan L; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Ma XY; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Zhao S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Song XQ; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Yang WT; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Chai WJ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Guo XM; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Chen XZ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Xu YH; Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Zhu XY; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Zou JJ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Wang ZH; Precision Cancer Medical Center Affiliated to Fudan University Shanghai Cancer Center, Shanghai, 201315, China.
  • Jiang YZ; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Shao ZM; Laboratory Animal Center, Fudan University Shanghai Cancer Center, Shanghai, 201315, China.
Mol Cancer ; 21(1): 84, 2022 03 25.
Article in En | MEDLINE | ID: mdl-35337339
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: China